Literature DB >> 12121788

Synthesis, structure, spectroscopic and in vitro antitumour studies of a novel gallium(III) complex with 2-acetylpyridine (4)N-dimethylthiosemicarbazone.

Vladimir B Arion1, Michael A Jakupec, Markus Galanski, Peter Unfried, Bernhard K Keppler.   

Abstract

The reaction of 2-acetylpyridine 4N-dimethylthiosemicarbazone (HL) with GaCl(3) in absolute ethanol in 1:1 molar ratio yielded the complex [GaL(2)][GaCl(4)]. The crystal structure of the gallium(III) complex has been determined by X-ray diffraction methods. Infrared, electronic, ESI mass and (1)H, (13)C, (15)N and (71)Ga NMR spectra, as well as the thermal behaviour are reported. The cytotoxicity assay in several human cancer cell lines (SW480, SK-BR-3 and 41M) suggests that the gallium(III) complex might be endowed with promising antitumour properties. In vitro cytotoxic activity exceeds that of all other tested gallium(III) complexes and is slightly higher than that of HL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121788     DOI: 10.1016/s0162-0134(02)00419-1

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  13 in total

1.  A novel gallium compound synergistically enhances bortezomib-induced apoptosis in mantle cell lymphoma cells.

Authors:  Christopher R Chitambar; David P Purpi
Journal:  Leuk Res       Date:  2010-03-24       Impact factor: 3.156

Review 2.  Gallium-containing anticancer compounds.

Authors:  Christopher R Chitambar
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

3.  One Pot Synthesis, Photophysical and X-ray Studies of Novel Highly Fluorescent Isoquinoline Derivatives with Higher Antibacterial Efficacy Based on the In-vitro and Density Functional Theory.

Authors:  Abdullah M Asiri; Salman A Khan; Saad H Al-Thaqafy; Kamlesh Sharma
Journal:  J Fluoresc       Date:  2015-03-05       Impact factor: 2.217

4.  Cytotoxic gallium complexes containing thiosemicarbazones derived from 9-anthraldehyde: Molecular docking with biomolecules.

Authors:  Floyd A Beckford; Alyssa Brock; Antonio Gonzalez-Sarrías; Navindra P Seeram
Journal:  J Mol Struct       Date:  2016-05-24       Impact factor: 3.196

5.  Cytotoxicity, apoptosis and study of the DNA-binding properties of bi- and tetranuclear gallium(III) complexes with heterocyclic thiolato ligands.

Authors:  Beatriz Gallego; Milena R Kaluđerović; Harish Kommera; Reinhard Paschke; Evamarie Hey-Hawkins; Torsten W Remmerbach; Goran N Kaluđerović; Santiago Gómez-Ruiz
Journal:  Invest New Drugs       Date:  2010-05-15       Impact factor: 3.850

Review 6.  Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.

Authors:  Christopher R Chitambar; William E Antholine
Journal:  Antioxid Redox Signal       Date:  2012-10-03       Impact factor: 8.401

Review 7.  Medical applications and toxicities of gallium compounds.

Authors:  Christopher R Chitambar
Journal:  Int J Environ Res Public Health       Date:  2010-05-10       Impact factor: 3.390

8.  Synthesis, Structure, and Antiproliferative Activity of Three Gallium(III) Azole Complexes.

Authors:  Stergios Zanias; Giannis S Papaefstathiou; Catherine P Raptopoulou; Konstantinos T Papazisis; Vasiliki Vala; Dimitra Zambouli; Alexandros H Kortsaris; Dimitrios A Kyriakidis; Theodoros F Zafiropoulos
Journal:  Bioinorg Chem Appl       Date:  2010-07-18       Impact factor: 7.778

9.  Antineoplastic Activity of New Transition Metal Complexes of 6-Methylpyridine-2-carbaldehyde-N(4)-ethylthiosemicarbazone: X-Ray Crystal Structures of [VO(2)(mpETSC)] and [Pt(mpETSC)Cl].

Authors:  Shadia A Elsayed; Ahmed M El-Hendawy; Sahar I Mostafa; Bertrand J Jean-Claude; Margarita Todorova; Ian S Butler
Journal:  Bioinorg Chem Appl       Date:  2010-07-01       Impact factor: 7.778

10.  Cu(ii), Ga(iii) and In(iii) complexes of 2-acetylpyridine N(4)-phenylthiosemicarbazone: synthesis, spectral characterization and biological activities.

Authors:  Yu-Ting Wang; Yan Fang; Meng Zhao; Ming-Xue Li; Yu-Mei Ji; Qiu-Xia Han
Journal:  Medchemcomm       Date:  2017-10-09       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.